Rajneet K Oberoi Selected Research

P-300

4/2018	Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis.
4/2018	Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection.
1/2018	Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rajneet K Oberoi Research Topics

Disease

8	Infections 01/2020 - 01/2018
4	Heart Failure 12/2021 - 01/2021
3	Chronic Hepatitis C 01/2020 - 01/2018
3	Glioblastoma (Glioblastoma Multiforme) 01/2016 - 12/2013
3	Glioma (Gliomas) 09/2015 - 12/2013
2	Fibrosis (Cirrhosis) 04/2018 - 01/2018
2	Neoplasms (Cancer) 01/2016 - 09/2015
2	Brain Neoplasms (Brain Tumor) 01/2016 - 09/2015
2	Breast Neoplasms (Breast Cancer) 09/2015 - 12/2013
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Headache (Headaches) 01/2020
1	Liver Diseases (Liver Disease) 01/2019
1	Virus Diseases (Viral Diseases) 01/2018

Drug/Important Bio-Agent (IBA)

6	glecaprevir and pibrentasvirIBA 01/2020 - 01/2018
4	Cardiac MyosinsIBA 12/2021 - 01/2021
4	omecamtiv mecarbilIBA 12/2021 - 01/2021
4	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2018
4	glecaprevirIBA 01/2020 - 01/2018
3	pibrentasvirIBA 01/2020 - 01/2018
3	P-300IBA 04/2018 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2013
2	Ribavirin (Virazole)FDA LinkGeneric 01/2020 - 01/2018
2	InterferonsIBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2016 - 09/2015
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2015 - 12/2013
2	Sunitinib (Sutent)FDA Link 12/2013 - 12/2013
1	risankizumabIBA 01/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2020
1	Reducing AgentsIBA 01/2019
1	AcidsIBA 01/2019
1	ombitasvirIBA 04/2018
1	paritaprevirIBA 04/2018
1	Ritonavir (Norvir)FDA Link 04/2018
1	TabletsIBA 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2018
1	GNE-317IBA 09/2015
1	1- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA 09/2015
1	Phosphotransferases (Kinase)IBA 09/2015
1	Tyrosine Kinase InhibitorsIBA 12/2013
1	ElacridarIBA 12/2013

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2016 - 12/2013
1	Electrodes (Electrode) 01/2020
1	Therapeutics 01/2016